Dose optimization of cefotaxime as pre-emptive treatment in critically ill adult patients: A population pharmacokinetic study.

Publication Year: 2022

DOI:
10.1111/bcp.15487

PMCID:
PMC10087439

PMID:
35942921

Journal Information

Full Title: Br J Clin Pharmacol

Abbreviation: Br J Clin Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data s2 supporting information click here for additional data file."

Code Sharing
Evidence found in paper:

"COMPETING INTEREST There are no competing interests to declare."

Evidence found in paper:

"Funding information The study was performed at the Erasmus MC and the Maasstad Hospital. The authors confirm that the Principal Investigators for this paper were Birgit Koch (Erasmus MC), Henrik Endeman (Erasmus MC) and Annemieke Dijkstra (Maasstad Hospital) and that they had direct clinical responsibility for patients."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025